findmyKOL

Justis Ehlers, MD

Enriched profile

Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research; Staff Physician, Vitreoretinal Service, Cole Eye Institute; Director, Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research · Cleveland Clinic

ORCIDNPI
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding2013–2019

Justis Ehlers is Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research; Staff Physician, Vitreoretinal Service, Cole Eye Institute; Director, Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research at Cleveland Clinic. OpenAlex indexes 444 publications with 10,081 citations (h-index 55); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Justis Ehlers, M.D., is Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research at Cleveland Clinic, Cole Eye Institute, Department of Ophthalmology. The public record shows 444 publications with 10,081 citations (h-index 55), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Macular Surgery. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 20 companies, 2 NIH-funded awards (2013–2019).

  • Most recent indexed publication: 2025 · Diagnostics (Basel, Switzerland)
  • Top research focus: Retinal Diseases and Treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Edema3 trialsDiabetic Complications2 trialsDiabetic Retinopathy / DME2 trialsMacular Edema2 trialsRetinal Detachment2 trialsEpiretinal Membrane2 trialsFuchs' Endothelial Dystrophy2 trialsRetinal Diseases1 trialRetinal Vein Occlusion1 trialCardiovascular Diseases1 trialPeripheral Arterial Disease1 trialThrombosis1 trialVascular Diseases1 trialLymphedema1 trialAneurysm1 trialVasculitis1 trialSpasm1 trialLipedema1 trialThoracic Outlet Syndrome1 trialMay-Thurner Syndrome1 trialFibromuscular Dysplasia1 trialDissection, Blood Vessel1 trialMacular Degeneration (AMD)Glaucoma

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Macular SurgeryRetinal and Optic ConditionsGlaucoma and retinal disorders

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trialsIndustry payments15Publications1Beovugeneric · BrolucizumabClinical trialsIndustry payments6PublicationsOzurdexgeneric · DexamethasoneClinical trialsIndustry payments6Publications

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim International GmbHClinical trialsIndustry payments50Alcon Vision LLCClinical trialsIndustry payments22Regeneron Pharmaceuticals, Inc.Clinical trialsIndustry payments20

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
444publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

10,081citations

Total citations across indexed works.

55h-index

Hirsch index (OpenAlex). i10-index 181.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2013–2019

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85.7%
    Corticosteroid41.6%
    Prednisolone Acetate100%
    Part D67 patients
    Quinolone Antimicrobial21.2%
    Ofloxacin100%
    Part D55 patients
  • Musculoskeletal

    14.3%
    Cyclooxygenase Inhibitor14.3%
    Ketorolac Tromethamine100%
    Part D18 patients
Where care is delivered (Part B)38.6% facility · 61.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

2 NIH research awards on record, funded 20132019 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/justis-ehlers-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/justis-ehlers-8bb7b49

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • Google Scholar

    scholar.google.com/citations

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholar.google.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/OphthalmologyTimes/videos/icymi-justis-p-ehlers-md/2502296326687316

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Facebook

    facebook.com/cleyebankfoundation/posts/-meet-the-researcher-justis-ehlers-md-justis-p-ehlers-md-serves-as-the-norman-c-/918267640333797

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/retina_today/p/C8DT0lDM8Va

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Ophthalmology

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org
  • MD

    Washington University School of Medicine

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org
  • BS

    University of Notre Dame

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org

Editorial & leadership roles

journal and society appointments
  • Council member

    American Academy of Ophthalmology

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lerner.ccf.org
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lerner.ccf.org
  • Co-chief Editor

    Wills Eye Manual, 5th edition

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lerner.ccf.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
5 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Q&A feature

    Ophthalmology Times, on the Phase 1 HELIOS NPDR trial results

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmologytimes.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.